V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180012276 | 180002652 | null | null | null | 2021-04-20 | 2022-01-31 | null | null | null | LENVATINIB | 101017820 |
| 180012379 | 180002657 | null | null | null | null | 2019-02-02 | NB HRNBL-1 TVD | null | null | FLUOROURACIL + OXALIPLATIN | 100050477 |
| 180012461 | 180002658 | null | null | null | null | 2017-07-02 | NB 13 cis-RA (Isotretinoin) | null | null | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 100898426 |
| 180012541 | 180002662 | null | null | null | null | 2020-03-08 | Cisplatin + Paclitaxel | null | null | LENVATINIB | 101106401 |
| 180012563 | 180002663 | null | null | null | null | 2018-05-13 | Paclitaxel 7 day | null | null | BORTEZOMIB + THALIDOMIDE | 101633799 |
| 180012566 | 180002664 | null | null | null | null | 2021-12-19 | NB Rel CCLG guidelines Irin & Temoz | null | null | ETOPOSIDE | 100833094 |
| 180012588 | 180002667 | null | null | null | null | 2017-12-18 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 100117782 |
| 180012589 | 180002668 | null | null | null | null | 2018-07-29 | CABOZANTINIB | null | null | GEMCITABINE + OXALIPLATIN + PACLITAXEL | 100548072 |
| 180012596 | 180002669 | null | null | null | null | 2017-08-10 | PACLITAXEL | null | null | DINUTUXIMAB BETA | 101425806 |
| 180012614 | 180002670 | null | null | null | null | 2019-10-13 | NB BEACON Temoz Irin Bev | null | null | PACLITAXEL | 101753834 |
| 180012640 | 180002673 | null | null | null | 2020-06-10 | 2021-04-27 | null | null | null | CARBOPLATIN + PACLITAXEL | 101299721 |
| 180012642 | 180002674 | null | null | null | null | 2020-12-16 | CARBOPLATIN + GEMCITABINE + RITUXIMAB | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100210558 |
| 180012649 | 180002675 | null | null | null | null | 2018-11-20 | BUSULFAN + MELPHALAN | null | null | TRIAL | 101302561 |
| 180012691 | 180002677 | null | null | null | null | 2019-02-23 | CARBOPLATIN | null | null | NB HRNBL-1 TVD | 100810944 |
| 180012740 | 180002681 | null | null | null | null | 2017-11-27 | FLUOROURACIL + OXALIPLATIN | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101147318 |
| 180012861 | 180002685 | null | null | null | null | 2017-05-03 | DABRAFENIB + TRAMETINIB | null | null | ETOPOSIDE | 101155435 |
| 180012937 | 180002688 | null | null | null | null | 2016-07-05 | Dinutuximab Beta | null | null | NB HRNBL-1 ISOTRETINOIN | 101273780 |
| 180012941 | 180002689 | null | null | null | 2018-10-01 | 2018-10-15 | null | null | null | DINUTUXIMAB BETA | 100218966 |
| 180012969 | 180002692 | null | null | null | 2016-11-22 | 2016-11-22 | Cyclophosphamide High Dose | null | null | LENVATINIB | 100292945 |
| 180012978 | 180002693 | null | null | null | null | 2018-09-08 | MITOTANE | null | null | CARBOPLATIN + PEMETREXED | 101626024 |
| 180013211 | 180002702 | null | null | null | null | 2017-11-24 | Doxorubicin 75mg/m2 | null | null | NOT MATCHED | 101418833 |
| 180013286 | 180002704 | null | null | null | 2018-09-08 | 2018-09-21 | ETOPOSIDE | null | null | RITUXIMAB | 101071560 |
| 180013493 | 180002714 | null | null | null | null | 2018-09-18 | Paclitaxel 7 day | null | null | CARBOPLATIN + PACLITAXEL | 101442693 |
| 180000964 | 180002719 | null | null | null | 2021-05-10 | 2021-05-24 | null | null | null | CARBOPLATIN + PACLITAXEL | 100260458 |
| 180003586 | 180002732 | null | null | null | null | 2019-12-05 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100173608 |
| 180004053 | 180002734 | null | null | null | 2020-11-24 | 2020-12-25 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | NB HRNBL-1 ISOTRETINOIN | 101226306 |
| 180005565 | 180002742 | null | null | null | null | 2017-09-24 | Cisplatin + Paclitaxel | null | null | CABOZANTINIB | 100186592 |
| 180007170 | 180002748 | null | null | null | 2021-09-11 | 2021-09-23 | CARBOPLATIN | null | null | NOT MATCHED | 101811280 |
| 180007867 | 180002752 | null | null | null | null | 2019-09-27 | Capecitabine + Oxaliplatin 21day | null | null | CARBOPLATIN + PEMETREXED | 101807444 |
| 180009008 | 180002755 | null | null | null | null | 2017-09-17 | Irinotecan + Temozolomide | null | null | LENVATINIB | 101188516 |
| 180009343 | 180002757 | null | null | null | 2019-03-12 | 2020-03-17 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | LENVATINIB | 100054930 |
| 180009463 | 180002759 | null | null | null | null | 2017-08-22 | null | null | null | ALL UKALL2011 IND A | 100961749 |
| 180010000 | 180002762 | null | null | null | null | 2018-08-15 | CARBOPLATIN + GEMCITABINE | null | null | NOT MATCHED | 101820973 |
| 180010136 | 180002763 | null | null | null | null | 2019-08-09 | null | 2 | null | TIVOZANIB | 101402352 |
| 180010167 | 180002764 | null | null | null | 2020-02-11 | 2020-02-16 | NB HRNBL-1 TVD | null | null | LANREOTIDE | 101015413 |
| 180010649 | 180002766 | null | null | null | 2021-10-25 | 2021-11-11 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | null | null | SORAFENIB | 100113114 |
| 180011232 | 180002767 | null | null | null | null | 2019-02-23 | null | null | null | ETOPOSIDE | 101761358 |
| 180011645 | 180002770 | null | null | null | null | 2016-04-12 | ETOPOSIDE | null | null | NB BEACON TEMOZOLOMIDE, TOPOTECAN AND BEVACIZUMAB | 101622307 |
| 180012380 | 180002775 | null | null | null | 2022-04-19 | 2022-05-03 | CNS GCT II Germinoma - Ifos Etop | null | null | CAPECITABINE + GEMCITABINE | 100766805 |
| 180000079 | 180002790 | null | null | null | null | 2021-10-06 | LENVATINIB | null | null | NOT MATCHED | 101660769 |
| 180000098 | 180002791 | 1.74 | null | null | null | 2016-10-08 | CISPLATIN + FLUOROURACIL | null | null | LENVATINIB | 101425257 |
| 180000209 | 180002796 | null | null | null | null | 2019-06-29 | Dacarbazine | null | null | CABOZANTINIB | 100003728 |
| 180000253 | 180002797 | null | null | null | null | 2019-06-26 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | NB HRNBL-1 BUMEL MAT | 101246601 |
| 180000256 | 180002798 | null | null | null | 2022-03-12 | 2022-04-04 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | null | null | LENVATINIB | 100112665 |
| 180000408 | 180002807 | null | null | null | 2020-06-04 | 2020-06-09 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | NOT MATCHED | 100662834 |
| 180000413 | 180002809 | null | null | null | null | 2017-04-12 | Dinutuximab Beta | null | null | PACLITAXEL | 101220806 |
| 180000423 | 180002810 | null | null | null | 2020-02-21 | 2020-03-05 | CYCLO + DOXORUBICIN + VINCRISTINE | null | null | TRIAL UNSPECIFIED | 101219314 |
| 180000464 | 180002813 | null | null | null | 2019-05-28 | 2019-06-11 | Rituximab | null | null | ETOPOSIDE | 100857379 |
| 180000747 | 180002820 | null | null | null | 2014-09-13 | 2014-09-25 | Tretinoin | null | null | LENVATINIB | 100445297 |
| 180000768 | 180002821 | null | null | null | null | 2018-07-21 | CABOZANTINIB | null | null | CISPLATIN + FLUOROURACIL | 100508215 |